Espinoza Octavio
- SEC CIK
- 0001905248
In the past year, 4 open-market sale filings worth $13.0M and no purchases.
Current role at each company
- LGND Ligand Pharmaceuticals IncChief Financial Officeras of Aug 14, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $13.0M
- 4 filings
- Net
- −$13.0M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Espinoza Octavio as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 (view filing)5:05 PM ET | Aug 12 | 2 days | Espinoza OctavioChief Financial Officer | SSale | −31.6K | $292.07 | −$9.24M | −53.3%27.7K after | 10b5-1 |
| Mar 13, 2026 (view filing) | Mar 11 | 2 days | Espinoza OctavioChief Financial Officer | SSale | −3.06K | $225.00 | −$687.8K | −12.7%21.0K after | 10b5-1 |
| Mar 6, 2026 (view filing) | Mar 4 | 2 days | Espinoza OctavioChief Financial Officer | SSale | −13.4K | $205.83 | −$2.76M | −38.3%21.7K after | 11 lots10b5-1 |
| Dec 16, 2025 (view filing) | Dec 12 | 4 days | Espinoza OctavioChief Financial Officer | SSale | −1.80K | $188.31 | −$339.7K | −6.4%26.2K after | |
| May 13, 2025 (view filing) | May 9 | 4 days | Espinoza OctavioChief Financial Officer | PPurchase | +1.50K | $104.06 | +$156.1K | +5.7%27.9K after | 2 lots |
| Mar 6, 2025 (view filing) | Mar 4 | 2 days | Espinoza OctavioChief Financial Officer | SSale | −5.00K | $115.03 | −$575.1K | −20.9%18.9K after | |
| Dec 26, 2024 (view filing) | Dec 23 | 3 days | Espinoza OctavioChief Financial Officer | SSale | −2.10K | $116.37 | −$244.8K | −9.2%20.6K after | |
| Sep 24, 2024 (view filing) | Sep 20 | 4 days | Espinoza OctavioChief Financial Officer | SSale | −1.27K | $103.94 | −$132.5K | −4.9%24.6K after | 3 lots |
| May 17, 2024 (view filing) | May 15-17 | 2 days | Espinoza OctavioChief Financial Officer | SSale | −13.3K | $86.26 | −$1.15M | −36.2%23.4K after | 4 lots |
| Feb 29, 2024 (view filing) | Feb 28 | 1 day | Espinoza OctavioChief Financial Officer | SSale | −140 | $88.46 | −$12.4K | −0.5%29.8K after | |
| Nov 10, 2022 (view filing) | Nov 9 | 1 day | Espinoza OctavioChief Financial Officer | SSale | −1.70K | $75.64 | −$128.3K | −16.1%8.86K after |